Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "IMA"

4049 News Found

Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA
People | May 01, 2026

Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA

Tamir brings more than 20 years of experience in the medical technology sector


ARTEMIS study shows significant gains in adolescent mental health across urban slums in India
Healthcare | May 01, 2026

ARTEMIS study shows significant gains in adolescent mental health across urban slums in India

The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
Hospitals | May 01, 2026

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi

The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries


India's healthcare policymakers call for digital health expansion and system strengthening
Policy | May 01, 2026

India's healthcare policymakers call for digital health expansion and system strengthening

Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms


Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection
Drug Approval | May 01, 2026

Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection

Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities
Medical Device | April 30, 2026

Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities

Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities


Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
News | April 30, 2026

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

The agreement could rise to $900 million if key commercial milestones are met